Table 1_Association of pre-admission statin use with clinical outcomes in aneurysmal subar

A dataset of 821 patients from a multicenter, observational study assessing the association between pre-admission statin therapy and 30-day clinical outcomes after aneurysmal subarachnoid hemorrhage. The data includes 1,431 screened patients, with 367 in the statin group and 454 controls, analyzed using propensity score matching. It was authored by Zhihao Zhao and last updated in April 2026.

Use Cases

• Assess the association between pre-admission statin use and favorable 30-day outcomes based on modified Rankin Scale scores.
• Investigate interaction effects between statin therapy and baseline LDL-C levels mentioned in the subgroup analysis.
• Examine interaction effects between statin therapy and alcohol consumption status as described in the results.
• Compare clinical outcomes before and after propensity score matching to evaluate treatment effect robustness.

Strengths

• Data originates from a multicenter study across four Chinese tertiary medical centers, suggesting a multi-institutional perspective.
• Includes results from 1,431 screened patients, with 821 meeting inclusion criteria and 440 after propensity score matching.
• Study period spans 11 years from May 2012 to May 2023, providing a longitudinal real-world observation window.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count for the underlying dataset is unknown, which may limit suitability assessment.
• Data may reflect geographic bias inherent to its collection from four Chinese medical centers.

Provenance

Source

Zhihao Zhao via figshare

Collection Method

Multicenter, observational, real-world study using patient records and propensity score matching.

Time Range

May 2012 to May 2023

Freshness

Last updated 2026-04-30 04:16:21; freshness should be verified.

Geography

Four Chinese tertiary medical centers